Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease

• Shirley Uitte de Willige ,

  * E-mail: s.uittedewillige@erasmusmc.nl

  Affiliation Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

  http://orcid.org/0000-0002-2035-4485

  ⨯
• Fiona M. Keane,

  Affiliation Department of Molecular Hepatology, Centenary Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia

  ⨯
• David G. Bowen,

  Affiliation Department of Molecular Hepatology, Centenary Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia

  ⨯
• Joyce J. M. C. Malfliet,

  Affiliation Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• H. Emma Zhang,

  Affiliation Department of Molecular Hepatology, Centenary Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia

  ⨯
• Bharvi Maneck,

  Affiliations Department of Molecular Hepatology, Centenary Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia, AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

  ⨯
• Geoffrey W. McCaughan,

  Affiliations Department of Molecular Hepatology, Centenary Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia, AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

  ⨯
• Frank W. G. Leebeek,

  Affiliation Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Dingeman C. Rijken,

  Affiliation Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

  ⨯
• Mark D. Gorrell

  Affiliation Department of Molecular Hepatology, Centenary Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia

  ⨯